The “AiCubator” – a new way to collaborate in anti-infectives and support novel approaches
To promote ideas that might lead to the next resistance breaking anti-infective, AiCuris has invested in a program that will support young scientists to further develop their exciting novel approaches by learning from experts about pre-clinical and clinical drug development, as well as the pharmaceutical business characteristics. This newly launched initiative, an innovative corporate accelerator, AiCubator, will provide long-term support for selected anti-infective research and early pre-clinical stage projects.
Academic scientific groups or recently formed biotech start-ups with early stage anti-infectives projects are invited to apply to the AiCuris AiCubator. In this process the main focus lies on Gram-negative resistance-breaking antibiotics, as well as targeted antiviral therapies for the treatment of herpes virus, adenovirus, hepatitis B cure and respiratory viruses. Submitted projects will be evaluated by AiCuris experts on a number of criteria. Every year, up to three projects will be awarded with AiCubator Resident Status. Over a period of up to three years the winning projects will mainly benefit from expert scientific support to grow their underlying ideas and approaches to an advanced level. The program was designed to help scientists and start-ups build their own business by providing financing and business development advice.
“Sometimes, it is not the lack of a groundbreaking idea that prevents the development of a novel, innovative anti-infective drug. The lack of funding but also missing development and business experience as well as limited resources discourages young start-ups and scientific groups, thereby preventing the development of new therapeutic options,” said Holger Schmoll, CFO of AiCuris Anti-infective Cures GmbH. “As one of the leading companies in anti-infectives we are committed to help them grow their projects with our expertise, know-how and broad network in the field.”
AiCubator 2020 call - important dates and deadlines:
End of Submission period: November 30, 2020, mid-night
Announcement of best projects: December 15, 2020
Start of the AiCubator program: January 01, 2021
For more information on AiCubator visit: www.aicuris.com/AiCubator.